The FDA adverse-event record for other

Other Adverse Event Insights

The FDA Center for Veterinary Medicine database holds 327 adverse event reports for Other, distributed across 0 distinct breeds currently tracked in the system. Of those reports, 54 involved a death outcome, producing a 16.5% case-fatality rate among reported events, which reflects reporting severity bias rather than true population mortality. These figures are aggregated directly from openFDA's Animal & Veterinary Adverse Events endpoint and update as new voluntary submissions flow through pet owners, veterinarians, and drug manufacturers.

The most frequently reported clinical signs for Other are Lack of efficacy - NOS (69 reports), Death (45 reports), INEFFECTIVE, ANESTHESIA (44 reports), Lack of efficacy (ectoparasite) - flea (33 reports), with Lack of efficacy - NOS leading the reaction traffic at 69 submissions. On the product side, Nitenpyram is the single most-referenced drug with 59 reports, followed by Isoflurane (46), Device: Suture (28), Propofol (17). This combination surfaces which therapeutic classes generate the most adverse event chatter for this species, a useful starting point when comparing Other reporting patterns against other companion animals in the dataset.

Of the 199 Other reports with a coded outcome, Outcome Unknown accounts for the largest share at 61.3%. Annual submission volume spans 2,010 to 2,025 reports across the 16 years on file, a range that reflects evolving owner awareness, veterinary reporting habits, and new product approvals rather than stable underlying incidence. The breed-level table below breaks these patterns down further, showing how the 0 tracked other breeds compare on volume, deaths, and average age at report. As with all FDA adverse event data, correlation is the ceiling, causation requires clinical investigation beyond what these aggregates can provide.